Humanigen Inc. (HGEN) Prices 5M Share Common Offering at $18.50/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Humanigen Inc. (HGEN) Prices 5M Share Common Offering at $18.50/Sh

Humanigen Announces Pricing of Public Offering of Five Million Shares of Common Stock

March 30, 2021 8:08 PM EDT

BURLINGAME, Calif.--(BUSINESS WIRE)--

Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate lenzilumab, today announced that it has priced its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $18.50 per share, resulting in gross proceeds to Humanigen of approximately $92.5 million, before deducting underwriting discounts and commissions and offering expenses. The offering is expected to close on or about April 5, 2021. Humanigen also granted the underwriters a... More